Amyloid precursor protein expression is induced by tumor necrosis factor α in 3T3-L1 adipocytes

Journal of Cellular Biochemistry

Volumn 108, Issue 6, 2009, Pages 1418-1422

  Sommer, Grit ^a   Kralisch, Susan ^a   Lipfert, Jana ^a   Weise, Sebastian ^a   Krause, Kerstin ^a   Jessnitzer, Beate ^a   Lössner, Ulrike ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

3T3 L1 adipocyte; Adipokine; Amyloid precursor protein; TNF

Indexed keywords

AMYLOID PRECURSOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL PROLIFERATION; MICE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71749112802     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22382     Document Type: Article

References (32)

1. Bluher M, Windgassen M, Paschke R. 2000. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diab Care 23:1591-1592. (Pubitemid 30746135)
2. Dell'Agli M, Galli GV, Bosisio E, D'Ambrosio M. 2009. Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives. Bioorg Med Chem Lett 19:1858-1860.
3. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE. 2000. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14:1557-1569.
4. Fasshauer M, Paschke R. 2003. Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603.
5. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR. 2001a. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 21:319-329.
6. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. 2001b. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 288:1027-1031. (Pubitemid 33140987)
7. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. 2002. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084-1089. (Pubitemid 34687474)
8. Fasshauer M, Klein J, Lossner U, Paschke R. 2003. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 35:147-152. (Pubitemid 36577855)
9. Fuortes M, Melchior M, Han H, Lyon GJ, Nathan C. 1999. Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J Clin Invest 104:327-335.
10. Ge YW, Lahiri DK. 2002. Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimer's disease. Ann NY Acad Sci 973:463-467.
11. Gorospe EC, Dave JK. 2007. The risk of dementia with increased body mass index. Age Ageing 36:23-29. (Pubitemid 47078643)
12. Grilli M, Goffi F, Memo M, Spano P. 1996. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 271:15002-15007. (Pubitemid 26194981)
13. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. 2003. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163:1524-1528. (Pubitemid 36835095)
14. Hehner SP, Hofmann TG, Droge W, Schmitz ML. 1999. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163:5617-5623.
15. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91. (Pubitemid 23036092)
16. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668. (Pubitemid 26052915)
17. Laborda J. 1991. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998.
18. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M. 2006. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173. (Pubitemid 44168485)
19. Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE. 2008. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) 16:1493-1500. (Pubitemid 351915132)
20. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. 2003. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561-566. (Pubitemid 41623184)
21. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. 1994. The ubiquitinproteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785. (Pubitemid 24294453)
22. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273:32730-32738. (Pubitemid 28557658)
23. Razay G, Vreugdenhil A, Wilcock G. 2007. The metabolic syndrome and Alzheimer disease. Arch Neurol 64:93-96.
24. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. 2002. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51:1319-1336. (Pubitemid 34826596)
25. Sondag CM, Combs CK. 2006. Amyloid precursor protein cross-linking stimulates beta amyloid production and pro-inflammatory cytokine release in monocytic lineage cells. J Neurochem 97:449-461.
26. Stephens JM, Lee J, Pilch PF. 1997. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-976. (Pubitemid 27034588)
27. Valladares A, Roncero C, Benito M, Porras A. 2001. TNF-alpha inhibits UCP-1 expression in brown adipocytes via ERKs. Opposite effect of p38MAPK. FEBS Lett 493:6-11.
28. Vilcek J, Lee TH. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316. (Pubitemid 21906368)
29. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. 2005. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330:1360. (Pubitemid 40839562)
30. Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. 2002. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22:RC221.
31. Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T. 2007. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol 170:680-6692. (Pubitemid 47339404)
32. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946. (Pubitemid 32756432)